Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Gradishar

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
JCO Precision Oncology|September 11, 2020
Predicting Expected Absolute Chemotherapy Treatment Benefit in Women With Early-Stage Breast Cancer Using EndoPredict, an Integrated 12-Gene Clinicomolecular AssayHatem Soliman, Darl D Flake, Anthony Magliocco, et al.
Journal of Neuro-Oncology|January 29, 2013
Pharmacokinetics and efficacy of pemetrexed in patients with brain or leptomeningeal metastasesPriya Kumthekar, Sean A Grimm, Michael J Avram, et al.
Breast Cancer Research and Treatment|July 16, 2024
Feasibility and preliminary effects of the Fit2ThriveMB pilot physical activity promotion intervention on physical activity and patient reported outcomes in individuals with metastatic breast cancerSiobhan M Phillips, Julia Starikovsky, Payton Solk, et al.
Annals of Surgical Oncology|January 8, 2020
Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast CancerHatem Soliman, Susanne Wagner, Darl D Flake, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2025
Real-World Outcomes of Elacestrant in ER+, HER2-, ESR1-Mutant Metastatic Breast CancerHope S Rugo, Virginia Kaklamani, Heather McArthur, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 8, 2019
Feasibility and acceptability of intensive longitudinal data collection of activity and patient-reported outcomes during chemotherapy for breast cancerPayton Solk, Kara Gavin, Jason Fanning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2023
Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast CancerElena Shagisultanova, William Gradishar, Ursa Brown-Glaberman, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 30, 2022
Using ecological momentary assessment to understand associations between daily physical activity and symptoms in breast cancer patients undergoing chemotherapyMadelyn Whitaker, Whitney A Welch, Jason Fanning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2011
Cancer therapy associated bone loss: implications for hip fractures in mid-life women with breast cancerBeatrice J Edwards, Dennis W Raisch, Veena Shankaran, et al.
Breast Cancer Research and Treatment|May 2, 2019
Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy aloneIvana Sestak, Miguel Martín, Peter Dubsky, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
JCO Precision Oncology|September 11, 2020
Predicting Expected Absolute Chemotherapy Treatment Benefit in Women With Early-Stage Breast Cancer Using EndoPredict, an Integrated 12-Gene Clinicomolecular AssayHatem Soliman, Darl D Flake, Anthony Magliocco, et al.
Journal of Neuro-Oncology|January 29, 2013
Pharmacokinetics and efficacy of pemetrexed in patients with brain or leptomeningeal metastasesPriya Kumthekar, Sean A Grimm, Michael J Avram, et al.
Breast Cancer Research and Treatment|July 16, 2024
Feasibility and preliminary effects of the Fit2ThriveMB pilot physical activity promotion intervention on physical activity and patient reported outcomes in individuals with metastatic breast cancerSiobhan M Phillips, Julia Starikovsky, Payton Solk, et al.
Annals of Surgical Oncology|January 8, 2020
Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast CancerHatem Soliman, Susanne Wagner, Darl D Flake, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2025
Real-World Outcomes of Elacestrant in ER+, HER2-, ESR1-Mutant Metastatic Breast CancerHope S Rugo, Virginia Kaklamani, Heather McArthur, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 8, 2019
Feasibility and acceptability of intensive longitudinal data collection of activity and patient-reported outcomes during chemotherapy for breast cancerPayton Solk, Kara Gavin, Jason Fanning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2023
Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast CancerElena Shagisultanova, William Gradishar, Ursa Brown-Glaberman, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 30, 2022
Using ecological momentary assessment to understand associations between daily physical activity and symptoms in breast cancer patients undergoing chemotherapyMadelyn Whitaker, Whitney A Welch, Jason Fanning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2011
Cancer therapy associated bone loss: implications for hip fractures in mid-life women with breast cancerBeatrice J Edwards, Dennis W Raisch, Veena Shankaran, et al.
Breast Cancer Research and Treatment|May 2, 2019
Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy aloneIvana Sestak, Miguel Martín, Peter Dubsky, et al.
Pageof 8